Binding Assay Services

Overview

Understanding the binding interactions between therapeutic candidates and various biological targets is essential for optimizing efficacy, safety, and pharmacokinetics. At Creative Biolabs, we specialize in providing high-quality binding assay services that are critical for the development and characterization of therapeutic antibodies and proteins. Our extensive array of binding assays, including Fc receptor (FcR), neonatal Fc receptor (FcRn), and complement C1q binding assays, deliver accurate, reliable, and reproducible results. Utilizing state-of-the-art technologies and unmatched expertise, Creative Biolabs delivers comprehensive solutions to meet your research and development needs.

FcR Binding Assay

The FcR binding assay is crucial for understanding how therapeutic antibodies interact with the immune system. FcγRs are found on the surface of immune cells and play a crucial role in antibody-mediated effector functions such as antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cell-mediated phagocytosis (ADCP). Our FcR binding assay encompasses a broad range of Fc receptors, such as FcγRI (CD64), FcγRIIa (CD32a), FcγRIIb (CD32b), FcγRIIIa (CD16a), and FcγRIIIb (CD16b). Using advanced platforms such as surface plasmon resonance (SPR) and flow cytometry, we assess binding kinetics and affinity with high precision.

Fig.1 Types of FcRs.^{1, 4}

FcRn Binding Assay

FcRn is responsible for protecting IgG antibodies from lysosomal degradation, thereby extending their half-life in the circulatory system. Creative Biolabs provides precise FcRn binding assays to accurately measure the binding affinity of therapeutic antibodies under physiological conditions. Our FcRn binding assay services are meticulously designed to evaluate the binding characteristics of IgG antibodies to FcRn under both acidic and neutral pH conditions. By leveraging our expertise, we help you optimize your therapeutic candidates for better pharmacokinetics and biodistribution.

Fig.2 FcRn-mediated recycling and transcytosis.^{2, 4}

Complement C1q Binding Assay

The complement system, especially the first component C1q, is integral to initiating the classical pathway of complement activation, which leads to the elimination of pathogens and altered cells. Our Complement C1q Binding Assay allows for the detailed evaluation of these interactions, offering insights into the antibody's potential to induce complement-dependent cytotoxicity (CDC). Employing techniques like ELISA and SPR, our assays deliver comprehensive data on C1q binding.

Our Technologies and Methods

At Creative Biolabs, we utilize cutting-edge platforms such as SPR, ELISA, and flow cytometry to ensure the highest accuracy and reliability in our binding assays. Choosing the best method for binding assays depends on the specific requirements of your study. By selecting the appropriate method, Creative Biolabs ensures that you receive the most relevant and accurate data for your therapeutic antibody and protein development projects.

• SPR and BLI are often considered the gold standards due to their ability to provide real-time kinetic data and high sensitivity.
• Flow Cytometry-based assays offer high-throughput capabilities and are particularly effective for cellular binding studies.
• ELISA, with its high specificity and sensitivity, is particularly useful for quantifying protein-protein interactions.

Workflow: A Seamless Path to Binding Insights

Our streamlined workflow at Creative Biolabs ensures a comprehensive, efficient, and transparent process, designed for clarity and optimal results. We prioritize clear communication and scientific rigor at every stage.

Required Starting Materials:

• Target protein/ligand: Purified and well-characterized, with a known concentration and information regarding its stability and storage conditions.
• Therapeutic candidate: Your specific antibody, small molecule compound, nucleic acid, or other binding partner, along with any relevant purity and concentration data.
• Project objectives: A clear definition of your specific goals, such as precise affinity determination, detailed kinetic analysis, high-throughput screening for lead discovery, or specificity assessment against a panel of related targets.

Final Deliverables:

• Comprehensive binding assay report: A detailed document including all raw data, analyzed binding curves, calculated binding parameters, and an expert scientific interpretation of the findings.
• Detailed methodologies and protocols: Full documentation of the experimental setup, reagent information, and precise procedures used, ensuring transparency and reproducibility for your records.
• Expert scientific consultation: A dedicated follow-up session with our lead scientists to review the results, discuss implications, and strategize future research directions.

Publication

This publication describes the development of a novel plate-based immunoassay to measure the binding affinity of antibodies to Fc-gamma receptors (FcγRs). The new assay uses a luminescent protein complementation technology, which offers a solution-based format to minimize surface-related artifacts common in traditional biosensor platforms. The authors validated the FcγR assays and demonstrated that they are specific, report IgG subclass-specific affinities, and can detect changes in Fc/FcγR interactions. The study highlights the advantages of this parallel screening method for accelerating the discovery of new therapeutic antibody drugs by enabling the simultaneous measurement of binding affinities for a large panel of antibodies against a family of FcγRs.

Fig.3 Schematic presentation of a FcγR immunoassay.^{3, 4}

Why Choose Us?

Choosing Creative Biolabs for your binding assay needs means partnering with a recognized leader in molecular interaction analysis. Our unwavering commitment to scientific excellence, combined with our cutting-edge technologies and client-centric approach, uniquely positions us to accelerate your drug discovery journey.

Advantages:

• High sensitivity and specificity: Ensuring accurate detection of binding interactions with minimal background noise.
• Real-time monitoring: Providing dynamic insights into binding kinetics.
• High throughput: Enabling the analysis of multiple samples simultaneously for efficient data generation.
• Quantitative and qualitative data: Offering comprehensive insights into binding affinities and mechanisms.

Don't hesitate to contact us even if you're unsure about specific details; we're here to guide you through the process!

FAQs

Customer Review

Related Services

To further support your drug discovery and development efforts, Creative Biolabs offers a suite of complementary services that often go hand-in-hand with our binding assay services, providing a holistic solution for your research needs:

How to Contact Us

Ready to unlock the full potential of your therapeutic candidates? Our team of experienced scientists at Creative Biolabs is eager to discuss your specific project requirements and design a customized binding assay strategy that meets your unique needs.

Contact Our Team for More Information!

References

1. Ben Mkaddem, Sanae, Marc Benhamou, and Renato C. Monteiro. "Understanding Fc receptor involvement in inflammatory diseases: from mechanisms to new therapeutic tools." Frontiers in Immunology 10 (2019): 811. DOI: https://doi.org/10.3389/fimmu.2019.00811
2. Sand, Kine Marita Knudsen, et al. "Unraveling the interaction between FcRn and albumin: opportunities for design of albumin-based therapeutics." Frontiers in Immunology 5 (2015): 682. DOI: https://doi.org/10.3389/fimmu.2014.00682
3. Nath, Nidhi, et al. "A homogeneous bioluminescent immunoassay for parallel characterization of binding between a panel of antibodies and a family of Fcγ receptors." Scientific Reports 12.1 (2022): 12185. DOI: https://doi.org/10.1038/s41598-022-15887-z
4. Distributed under Open Access license CC BY 4.0, without modification.

For Research Use Only | Not For Clinical Use